In the US, breast cancer (BC) is the most common malignant neoplasm and the second leading cause of cancer deaths among women, with an estimated 287 850 new diagnoses and 43 250 deaths in 2022.
1,2 BC diagnosis and treatment can take a heavy toll on patients’ physical, mental, psychosocial, and financial health. Cancer treatment and care services require interdisciplinary and multidisciplinary collaborations and effective patient-clinician communication and shared decision-making, while respecting patient autonomy.
3 Some patients with cancer choose to decline treatment despite clinician recommendations and treatment benefits. Declining curative treatment can have a detrimental effect on these patients’ short-term and long-term health outcomes and quality of life.
4-6 Studies have documented elevated risks of all-cause and disease-specific mortality in patients with cancer who forgo treatment recommended by their clinicians.
7-11